Yale faculty and researchers are invited to workshops and Q&A sessions with leading experts in the biotech venture capital space who will provide guidance on how to commercialize their technology and attract investment.
*Lunch will be included.*
Events will be held at various auditoriums at Yale Medical School. Please check the date for the correct location.
12pm-1pm: Lunch and Q&A
Sept. 16 (Brady Auditorium, 310 Cedar St)
"What Biotech VC's Want (and Don't Want)"
Vikas Goyal, SR One (Corporate venture arm of Glaxo Smith Kline)
Colleen Cuffaro, Canaan Partners
Alex Rosen, Venrock
Vishwas Paralkar, Karos Pharmaceuticals
*Also: Learn about $100,000-$300,000 in funding available to Yale faculty from the Blavatnik Fund for Innovation at Yale!
Oct. 21 (Brady Auditorium, 310 Cedar St)
“Startups 2.0” presented by Lou Berneman, Founding Partner and Matt Cohen, Principal of Osage University Partners. Osage University Partners is a venture capital fund that invests exclusively in startups that are commercializing university research. Understand the current startup company process from idea to fundable entity. The seminar will explore these areas:
- Essential elements of a startup
- Company formation and organization
- Pitch deck and executive summary
- Investment Memo
Jan. 25 (Hope 216, 315 Cedar St)
RA Capital, Andrew Levin
Feb. 10 (Brady Auditorium, 310 Cedar St)
Mar. 10 (Brady Auditorium, 310 Cedar St)